OXT and craniopharyngioma: While the extent to which the oxytocin system is compromised in craniopharyngioma is not yet clear, supplementation with exogenous oxytocin poses a potential therapeutic avenue, by restoring the inflammatory activation caused by the cystic and solid components of craniopharyngioma.